Dementia in the elderly: the silent epidemic.

The graying of America will be accompanied by an epidemic of major proportions--dementia or intellectual impairment--that will have an impact on all aspects of the helath care system, particularly on the institutional component of the long-term care system. Health professionals; federal, state, and local health planners; families; and others must recognize that many ameliorable or curable physical and emotional diseases in the elderly are associated with intellectual impairment that may be difficult to distinguish from irreversible brain disease of the Alzheimer type. We present information on the cause, physiopathologic mechanism, clinical presentation, appropriate laboratory studies, and anticipated outcomes in the various forms of intellectual impairment found in the elderly. Important new developments will occur in the next decade that will address the cause, pathogenesis, further refinement of laboratory investigation, and specific therapeutic intervention in dementia.

[1]  A. Kaszniak,et al.  Cerebral atrophy, EEG slowing, age, education, and cognitive functioning in suspected dementia , 1979, Neurology.

[2]  F. Plum Dementia: an approaching epidemic , 1979, Nature.

[3]  M. Diamond,et al.  Occipital cortical morphology of the rat: Alterations with age and environment , 1980, Experimental Neurology.

[4]  E. Bird,et al.  Pre- and postsynaptic neurochemical alterations in Alzheimer's disease , 1978, Brain Research.

[5]  R. Bartus,et al.  Brain cholinergic dysfunction and memory in aged rats , 1980, Neurobiology of Aging.

[6]  P. Davies,et al.  SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE , 1976, The Lancet.

[7]  G. Glenner,et al.  Amyloidosis: its nature and pathogenesis. , 1973, Seminars in hematology.

[8]  K. Davis,et al.  Physostigmine: improvement of long-term memory processes in normal humans. , 1978, Science.

[9]  G. Blessed,et al.  NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA , 1977, The Lancet.

[10]  D. Crapper,et al.  Aluminium, neurofibrillary degeneration and Alzheimer's disease. , 1976, Brain : a journal of neurology.

[11]  Scheibel Ab Dendritic changes in senile and presenile dementias. , 1979 .

[12]  R. Katzman.,et al.  Editorial: The prevalence and malignancy of Alzheimer disease. A major killer. , 1976, Archives of neurology.

[13]  M. Ron,et al.  Diagnostic Accuracy in Presenile Dementia , 1979, British Journal of Psychiatry.

[14]  P. Davies,et al.  Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile Dementia of the Alzheimer type , 1981, Neurobiology of Aging.

[15]  K. Squires,et al.  Long latency event-related components of the auditory evoked potential in dementia. , 1978, Brain : a journal of neurology.

[16]  C. Marsden,et al.  Outcome of Investigation of Patients with Presenile Dementia , 1972, British medical journal.

[17]  M. Albert,et al.  The `subcortical dementia' of progressive supranuclear palsy , 1974, Journal of neurology, neurosurgery, and psychiatry.

[18]  G. Lynch,et al.  Neuroplasticity in the hippocampal formation. , 1978, Progress in brain research.

[19]  A. Scheibel,et al.  The aging human betz cell , 1977, Experimental Neurology.

[20]  W. Meier-Ruge,et al.  ACCELERATED AGEING OR SELECTIVE NEURONAL LOSS AS AN IMPORTANT CAUSE OF DEMENTIA? , 1979, The Lancet.

[21]  I. Glen,et al.  CLINICAL EFFECTS OF CHOLINE IN ALZHEIMER SENILE DEMENTIA , 1977, The Lancet.

[22]  R. D. Adams,et al.  The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. , 1965, Journal of the neurological sciences.

[23]  Alistair Burns,et al.  Observations on the brains of demented old people. B.E. Tomlinson, G. Blessed and M. Roth, Journal of the Neurological Sciences (1970) 11, 205–242; (1968) 7, 331–356 , 1997 .

[24]  B. Reisberg,et al.  Long-term choline treatment of memory-impaired elderly patients. , 1979, Science.

[25]  K. Squires,et al.  Event Related Potentials in Development, Aging and Dementia , 1979 .

[26]  M. Roth,et al.  The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.

[27]  E K Perry,et al.  Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. , 1978, British medical journal.

[28]  Wells Ce Chronic brain disease: an overview. , 1978 .

[29]  S. Corkin,et al.  Neurochemical approaches to the treatment of senile dementia. , 1980, Proceedings of the annual meeting of the American Psychopathological Association.

[30]  M. Huckman,et al.  The validity of criteria for the evaluation of cerebral atrophy by computed tomography. , 1975, Radiology.

[31]  S. Mccann,et al.  Paradoxical elevation of growth hormone by intraventricular somatostatin: possible ultrashort-loop feedback. , 1981, Science.

[32]  M. Naeser,et al.  Decreased Computerized Tomography Numbers in Patients With Presenile Dementia: Detection in Patients With Otherwise Normal Scans , 1980 .

[33]  E. Hoffman,et al.  Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method , 1979, Annals of neurology.

[34]  K. Iqbal,et al.  Brain aluminum in aging and Alzheimer disease , 1979, Neurology.

[35]  B. Carroll,et al.  A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. , 1981, Archives of general psychiatry.

[36]  Arnold B. Scheibel,et al.  Structural Changes in the Aging Brain , 1975 .

[37]  R. Wurtman,et al.  Brain acetylcholine: control by dietary choline. , 1976, Science.

[38]  L. Kiloh,et al.  THE INVESTIGATION OF DEMENTIA: RESULTS IN 200 CONSECUTIVE ADMISSIONS , 1981, The Lancet.

[39]  M. Fisher,et al.  OLD PEOPLE AT HOME. THEIR UNREPORTED NEEDS. , 1964, Lancet.

[40]  Wells Ce Diagnostic evaluation and treatment in dementia. , 1977 .

[41]  E. Stengel PSYCHOPATHOLOGY OF DEMENTIA. , 1964, Proceedings of the Royal Society of Medicine.

[42]  W. Bondareff,et al.  Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia , 1982, Neurology.

[43]  R. Bartus Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: Effects of concurrent administration of physostigmine and methylphenidate with scopolamine , 1978, Pharmacology Biochemistry and Behavior.